603351.SS · 威尔药业
China A-shares · RS rating 84 · As of 2026-10-14
| Price | 26.25 CNY |
|---|---|
| 1-day change | -1.4% |
| RS rating (overall / 1M / 3M / 12M) | 84 / 84 / 59 / 64 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 36 / 35 / 27 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +7.6% |
| Distance from 52-week high | +12.8% |
| Market cap (USD) | $577.1M |